Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual Agonists [Internet]
Rest assured, at Klinic, we provide comprehensive "prior authorization support" and verify your insurance benefits for you
Prescription weight loss medications, including GLP-1s, are considered safe when used under medical supervision
GLP-1R activation triggers: Glucose-dependent insulin secretion from -cells (does not cause insulin release at normal glucose concentrations the basis for low hypoglycemia risk) Glucagon suppression from pancreatic -cells, reducing hepatic glucose output Delayed gastric emptying, smoothing postprandial glucose excursions Hypothalamic appetite suppression via arcuate nucleus GLP-1R signaling, reducing meal frequency and energy intake Direct cardiac effects including reduced ischemia-reperfusion injury (emerging research area) Renal protective effects via GLP-1R on kidney tubular cells Semaglutide's Research Profile Semaglutide provides the cleanest GLP-1-only research signal of the three compounds any observed effect can be attributed specifically to GLP-1R activation
US$ 21.87
US$ 22.94
US$ 27.13
US$ 28.89
US$ 22.60
